Clinical Trials Logo

Active Non-segmental Vitiligo clinical trials

View clinical trials related to Active Non-segmental Vitiligo.

Filter by:
  • None
  • Page 1

NCT ID: NCT03715829 Completed - Clinical trials for Active Non-segmental Vitiligo

A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects

Start date: November 26, 2018
Phase: Phase 2
Study type: Interventional

This is a Phase 2b, randomized, double blind, parallel group, multicenter study with an extension period. The study will have a maximum duration of approximately 60 weeks. This includes an up to 4 weeks Screening Period, a 24 week dose ranging period, an up to 24 week extension period and a 8 week Follow up Period.